Exp Clin Endocrinol Diabetes 2018; 126(06): e1
DOI: 10.1055/a-0650-8694
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Correction: Amiodarone-Induced Thyroid Dysfunction: A Clinical Update

Mohamed Nabil Elnaggar
1   Department of Endocrinology, Diabetes & Metabolism, University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom, LA1 4RP
4   Internal Medicine Department, Faculty of Medicine, Kafr El-Sheikh University, Kafr El-Sheikh, Egypt
,
Kahtan Jbeili
1   Department of Endocrinology, Diabetes & Metabolism, University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom, LA1 4RP
,
Nik Nik-Hussin
2   Department of Radiology and Nuclear Imaging Services, University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom, LA1 4RP
,
Mohandas Kozhippally
3   Department of Medicine, Good Hope Hospital, Heart of England NHS Foundation Trust, Birmingham, United Kingdom, B75 7RR
,
Joseph M Pappachan
1   Department of Endocrinology, Diabetes & Metabolism, University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom, LA1 4RP
› Author Affiliations
Further Information

Publication History

Publication Date:
04 July 2018 (online)

 

#

Erratum

Elnaggar MN, Jbeili K, Nik-Hussein, N et al. Amiodarone-Induced Thyroid Dysfunction: a Clinical Update.

Exp Clin Endocrinol Diabetes 2018; 126: 333–341
DOI: 10.1055/a-0577-7574

In the above mentioned article was a mistake in two sentences. Correct is: A matched cohort study in patients with AIT-2 comparing the efficacy of glucocorticoids against thionamides showed that at 40 days of treatment 23.8±9.3 % remained thyrotoxic in the former group compared to 85.7±7.6 % in the latter group [45].

Therefore, Thionamides may be considered as “having no role” in this subtype of AIT [14, 44, 45].


#
#